Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Hikma Pharmaceuticals ( (GB:HIK) ) has shared an update.
Hikma Pharmaceuticals reported that Hussein Arkhagha, a person discharging managerial responsibilities, purchased 6,200 ordinary shares in the company at £12.00 per share on 9 March 2026. The transaction, conducted on the London Stock Exchange and valued at £74,400, was disclosed under EU market abuse regulations, signalling internal management confidence and providing additional transparency for investors.
The share purchase by a senior manager may be interpreted by the market as a positive signal about Hikma’s prospects and governance standards. Such insider buying activity is often closely watched by shareholders and analysts, as it can reflect alignment between management and investors and may influence sentiment toward the company’s stock.
The most recent analyst rating on (GB:HIK) stock is a Buy with a £1800.00 price target. To see the full list of analyst forecasts on Hikma Pharmaceuticals stock, see the GB:HIK Stock Forecast page.
Spark’s Take on GB:HIK Stock
According to Spark, TipRanks’ AI Analyst, GB:HIK is a Neutral.
The score is held back primarily by weakening cash generation and a notably bearish technical trend (oversold and trading below key moving averages). These are partially offset by attractive valuation (low P/E and strong dividend yield) and a constructive earnings-call outlook supported by guidance comfort and a GBP 250m buyback, despite near-term injectable headwinds.
To see Spark’s full report on GB:HIK stock, click here.
More about Hikma Pharmaceuticals
Hikma Pharmaceuticals is a multinational generic and specialty pharmaceuticals manufacturer listed in London and on Nasdaq Dubai. The company focuses on developing, manufacturing and marketing branded and non-branded injectables, generics and branded medicines, serving hospitals and healthcare systems in global markets.
Average Trading Volume: 1,133,680
Technical Sentiment Signal: Sell
Current Market Cap: £2.62B
Find detailed analytics on HIK stock on TipRanks’ Stock Analysis page.